Browse by category

The FDA has approved a labelling update for VIVUS’ QSYMIA (phentermine and topiramate extended-release capsules CIV) that has removed the...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

People with opioid or alcohol use disorder (OUD, AUD) who take glucagon-like peptide-1 receptor agonists (GLP-1 RAs) to treat...

Laparoscopic Roux-en-Y fistulojejunostomy (LRYFJ) is an appropriate surgical option for the treatment of chronic gastric leaks after...

Expanding access to the new generation of weight-loss medications could prevent more than 40,000 deaths a year in the US, according to a...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are cost effective in the long term only when combined with bariatric surgery,...

Phenomix Sciences has formed a new partnership to advance precision medicine in obesity with InformedDNA, that integrates Phenomix’s...

Banded- Roux-en-Y gastric bypass (RYGB) is associated with statistically significant increases in percentage excess weight loss (% EWL)...

Symptoms of dumping syndrome and post-bariatric hypoglycaemia (PBH) appears to be more prevalent after RYGB, compared to LSG, whilst...

A systematic review has concluded that magnetic sphincter augmentation may represent a feasible, safe, and less invasive option compared...